Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors
Clinical trial NCT05150457 · UNKNOWN
Trial details
- NCT number
- NCT05150457
- Sponsor
- Binacea Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2023-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.